SEATTLE, March 16, 2021, (MEDGADGET) — Blood collection devices plays a crucial role in the patient treatment. For the treatment, blood samples are collected to measure the basic metabolism components such as blood urea nitrogen, sodium, potassium, creatinine, magnesium, chloride, and also used to measure blood glucose and lipid levels. Technological advancements in the blood collection device such as automated method of collection allows technologists to perform a greater variety of tests on smaller sample quantities with greater accuracy of outcomes compared to manual blood collection process. Therefore, there is an increasing number of laboratories taking their pace in the market from their hematology and chemistry analyzers to automated platforms.
Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-pdf/1160
Moreover, increasing demand for blood donations is expected to fuel demand of blood collection device market over the forecast period. For instance, according to the World Health Organization (WHO), 112.5 million blood donations collected globally and there is an increase of 10.7 million blood donations from unpaid donors has been reported from 2008 to 2013. Furthermore, according to the American National Red Cross, around 7,000 units of platelets and 10,000 units of plasma are required daily in the U.S. and nearly 21 million blood components are transfused each year in the U.S.
Increasing prevalence of certain disease conditions such as cancer, HIV/AIDS, diabetes, coronary heart disease, and anemia are expected to drive growth of the blood collection devices market. In addition, increasing numbers of surgeries and high demand for blood transfusion and casualty cases are further expected to drive growth of the blood collection devices market. For instance, according to the Centers for Disease Control and Prevention (CDC), in the U.S. 26,203 cases of Lyme disease was reported during 2006 and 2016. According to the same source, around 10,265 deaths were reported due to alcohol-impaired crashes in 2015, which accounted for around 29% of all traffic-related deaths in the U.S.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now this Premium Report to Grow your Business @ https://bit.ly/3vtRE7Q
Blood Collection Devices Market Taxonomy:
On the basis of product type, blood collection devices market is segmented into:
- Blood Collection Tubes
- Serum Collection Tubes
- Plasma Collection Tubes
- Heparin Tubes
- Other tubes (EDTA, ESR, and Microcapillary Tubes)
- Needles & Syringes
- Vacuum Blood Collection System
- Microfluidic System
- Blood Bags
On the basis of method of collection, blood collection devices market segmented into:
- Manual Blood Collection
- Automated Blood Collection
On the basis of end user, blood collection devices market segmented into:
- Hospitals and Nursing Homes
- Blood Banks
- Diagnostic Centers
- Research and Academic Organizations
- Home Care Settings
Continuous product advancement in blood collection devices fuel the growth of the market
Tasso, Inc., a company engaged in the manufacture of HemoLink, a simplified blood collection device used in the various diagnostic application received US$ 3 million funding from Defenses Advanced Research Projects Agency (DARPA) to advance their HemoLink technology by collaborating with GenTegra LLC, a company engaged in the manufacture of product used in the biopreservation, biobanking and in vitro diagnostics. Moreover the continuous product development and future advances in the blood collection techniques are expected to propel growth of the blood collection devices market.
Note: *The Download PDF brochure only consist of Table of Content, Research Framework, and Research Methodology.
Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-sample/1160
Recent FDA approvals to enter novel and technologically advanced blood collection devices in the market
DBS System SA- granted the USPTO patent for HemaXis Microfluidic blood collection platform in November 2017. HemaXis DB is microfluidic blood collection system, which uses the microfluidic chip with a standard filter card and protective case to provide the practical solution for blood collection procedure.
Seventh Sense Biosystems, Inc. in February 2017 received the U.S. FDA clearance for its new blood collection device, Touch Activated Phlebotomy (TAP). TAP is novel blood collection device used for convenient and painless blood testing. Moreover in October 2017, Ionis Pharmaceuticals, a company engaged in the RNA-targeted drug discovery and development to develop drug for severe and orphan disease entered into a collaboration with Seventh Sense Biosystems to support the development of improved blood collection and diagnostic device. The collaboration enables the further product development of TAP device for blood testing.
Velano Vascular, Inc. – a medical device company manufactures the needle-free, vascular device for blood collection, received the FDA approval for its updated version of needle-free blood draw device. The Velano device is designed to reduce blood draw related anxiety and discomfort in hospital patients allowing safer work environment for healthcare professionals. The FDA approved blood collection devices with their increased acceptability helps to favor the further growth of the market.
Key players in the blood collection devices market:
Some of the key players in the blood collection devices market include Becton, Dickinson and Company, NIPRO Medical Corporation, Terumo Medical Corporation, Medtronic plc, Qiagen, Bio-Rad Laboratories, Inc., Haemonetics Corporation, and Fresenius SE & Co. KGaA.
To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/blood-collection-devices-market-1160
Table of Content
Global Blood Collection Devices Market Research Report
Section 1: Global Blood Collection Devices Industry Overview
Section 2: Global Economic Impact on Blood Collection Devices Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Blood Collection Devices Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Blood Collection Devices Market Forecast
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027